Reviv3 Procare Company
RVIV · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | -0.06 | 1.35 |
| FCF Yield | 0.00% | 0.00% | 4.77% | -1.28% |
| EV / EBITDA | -1.09 | 50.91 | 25.72 | -57.54 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 23.31% | -45.33% |
| Gross Margin | 0.00% | 73.44% | 75.30% | 64.53% |
| Cash Conversion Ratio | – | – | 1.60 | 0.69 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | 127.47% | 143.28% | 32.13% |
| Free Cash Flow Growth | 71,945.61% | -99.91% | 2,362.89% | -482.00% |
| Safety | ||||
| Net Debt / EBITDA | -1.09 | -2.04 | -2.12 | 0.98 |
| Interest Coverage | 0.00 | 0.00 | 787.07 | -32.34 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 2.15 | 4.43 | 2.56 |
| Cash Conversion Cycle | 0.00 | 128.01 | 31.80 | -32.93 |